Interviews

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses promising specialty drugs to watch out for in the pipeline.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.

David DeRemer, PharmD, Assistant Director of Clinical Therapeutics and Incubator, Clinical Associate Professor at the University of Florida College of Pharmacy, discusses resources to help educate patients on oral chemotherapy agents.

As a part of the continuing effort to increase awareness and celebrate the pharmacy profession, Pharmacy Times and Specialty Pharmacy Times are partnering to launch the #APharmacistIs campaign.

In this clip, Randy Burkholder, Vice President of Policy and Research at PhRMA, discusses the health care policy changes that are needed to help alleviate the financial hardships faced by cancer patients.

Pharmacists have an important role in the care of oncology patients, especially in managing their treatments and providing support to physicians.

At the National Community Oncology Dispensing Association (NCODA) Fall Summit, Mario Lacouture, MD, discussed the importance of managing quality of life conditions, such as skin, hair, and nail conditions, in patients undergoing cancer treatments.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what role pharmacists have in combating the opioid epidemic.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the struggle with high-cost specialty medications and the alternatives for providing specialty pharmacy care.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, speaks to the merits of partnering with continuing education and advocacy organizations.

PQIs, developed by a team of NCODA clinical pharmacists, provide medication management tools that focus on specific issues associated with managing oral cancer drug therapies.

Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the potential impact biosimilars will have in health care.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, talks about using medical marijuana for the treatment of specialty conditions.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the impact of orphan drugs across the specialty landscape.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the negative impact of a slow turnaround on patient care.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.

Marc O’Connor, chief operating officer at Curant Health, highlights upcoming trends to pay attention to within the specialty pharmacy landscape.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses the importance of pharmacy residency programs.

Moses Zoanna, CEO of Compliance Meds Technologies, discusses the impact of mobile health.

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.

Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, examines the approaches specialty pharmacists can take to ensure adherence.